382 related articles for article (PubMed ID: 12037010)
1. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.
Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010
[TBL] [Abstract][Full Text] [Related]
2. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
Mori K; Gehlbach P; Ando A; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2428-34. PubMed ID: 12091447
[TBL] [Abstract][Full Text] [Related]
3. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.
Mori K; Duh E; Gehlbach P; Ando A; Takahashi K; Pearlman J; Mori K; Yang HS; Zack DJ; Ettyreddy D; Brough DE; Wei LL; Campochiaro PA
J Cell Physiol; 2001 Aug; 188(2):253-63. PubMed ID: 11424092
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization.
Zhou XY; Liao Q; Pu YM; Tang YQ; Gong X; Li J; Xu Y; Wang ZG
Chin Med J (Engl); 2009 Nov; 122(22):2711-7. PubMed ID: 19951601
[TBL] [Abstract][Full Text] [Related]
5. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.
Ogata N; Wada M; Otsuji T; Jo N; Tombran-Tink J; Matsumura M
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1168-75. PubMed ID: 11923262
[TBL] [Abstract][Full Text] [Related]
6. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
[TBL] [Abstract][Full Text] [Related]
7. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization.
Gehlbach P; Demetriades AM; Yamamoto S; Deering T; Duh EJ; Yang HS; Cingolani C; Lai H; Wei L; Campochiaro PA
Gene Ther; 2003 Apr; 10(8):637-46. PubMed ID: 12692592
[TBL] [Abstract][Full Text] [Related]
8. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
[TBL] [Abstract][Full Text] [Related]
9. Expression of pigment epithelium-derived factor in experimental choroidal neovascularization.
Renno RZ; Youssri AI; Michaud N; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1574-80. PubMed ID: 11980876
[TBL] [Abstract][Full Text] [Related]
10. Ocular gene transfer with self-complementary AAV vectors.
Yokoi K; Kachi S; Zhang HS; Gregory PD; Spratt SK; Samulski RJ; Campochiaro PA
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3324-8. PubMed ID: 17591905
[TBL] [Abstract][Full Text] [Related]
11. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.
Tong JP; Chan WM; Liu DT; Lai TY; Choy KW; Pang CP; Lam DS
Am J Ophthalmol; 2006 Mar; 141(3):456-62. PubMed ID: 16490490
[TBL] [Abstract][Full Text] [Related]
12. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
Duh EJ; Yang HS; Haller JA; De Juan E; Humayun MS; Gehlbach P; Melia M; Pieramici D; Harlan JB; Campochiaro PA; Zack DJ
Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
Hase R; Miyamoto M; Uehara H; Kadoya M; Ebihara Y; Murakami Y; Takahashi R; Mega S; Li L; Shichinohe T; Kawarada Y; Kondo S
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8737-44. PubMed ID: 16361561
[TBL] [Abstract][Full Text] [Related]
14. Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye.
Saishin Y; Silva RL; Saishin Y; Kachi S; Aslam S; Gong YY; Lai H; Carrion M; Harris B; Hamilton M; Wei L; Campochiaro PA
Hum Gene Ther; 2005 Apr; 16(4):473-8. PubMed ID: 15871678
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
16. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
[TBL] [Abstract][Full Text] [Related]
17. [Expression and signification of pigment epithelium-derived factor in experimental choroidal neovascularization of rat].
Shi XH; He SZ; Zhao SH
Zhonghua Yan Ke Za Zhi; 2004 Jun; 40(6):404-8. PubMed ID: 15312607
[TBL] [Abstract][Full Text] [Related]
18. [Pigment epithelium-derived factor gene therapy inhibits the growth of transplanted human hepatocellular carcinoma in nude mice].
GAO Y; ZHANG W; ZHAO L; WANG XH
Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):363-7. PubMed ID: 19497203
[TBL] [Abstract][Full Text] [Related]
19. Intraocular gene transfer of pigment epithelium-derived factor rescues photoreceptors from light-induced cell death.
Imai D; Yoneya S; Gehlbach PL; Wei LL; Mori K
J Cell Physiol; 2005 Feb; 202(2):570-8. PubMed ID: 15316929
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.
Matsumoto K; Ishikawa H; Nishimura D; Hamasaki K; Nakao K; Eguchi K
Hepatology; 2004 Jul; 40(1):252-9. PubMed ID: 15239109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]